This important observation prompted us to investigate the connection between this pro-survival Fas in EGF-dependent EGFR signaling in colorectal cancer cells, which represents the type of cancer to which anti-EGFR therapy is widely applied. This evidence concerns the gene FAS and colorectal cancer.